Mediwelcome Healthcare Management & Technology Inc. Statistics
Want to see HK:2159 full AI Analyst Report?
Mediwelcome Healthcare Management & Technology Inc. (2159) Stock Statistics & Valuation Metrics
Total Valuation
Mediwelcome Healthcare Management & Technology Inc. has a market cap or net worth of HKD 546.78M. The enterprise value is HKD 426.92M.
- Market Cap
- HKD 546.78M
- Enterprise Value
- HKD 426.92M
Share Statistics
Mediwelcome Healthcare Management & Technology Inc. has 336,480,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 336,480,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Mediwelcome Healthcare Management & Technology Inc.’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 1.14%.
- Return on Equity (ROE)
- 0.09
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 1.14%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 3.12M
- Profits Per Employee
- 66.59K
- Employee Count
- 150
- Asset Turnover
- 2.46
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Mediwelcome Healthcare Management & Technology Inc. is 10.12. Mediwelcome Healthcare Management & Technology Inc.’s PEG ratio is 0.01.
- PE Ratio
- 10.12
- PS Ratio
- 0.81
- PB Ratio
- 2.46
- Price to FCF
- 123.13
- Price to Operating Cash Flow
- 79.26
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Mediwelcome Healthcare Management & Technology Inc. had revenue of 468.02M and earned 9.99M in profits. Earnings per share was 0.04.
- Revenue
- 468.02M
- Gross Profit
- 94.71M
- Operating Income
- 1.82M
- Pretax Income
- 6.98M
- Net Income
- 9.99M
- EBITDA
- 6.67M
- Earnings Per Share (EPS)
- 0.04
Cash Flow
In the last 12 months, operating cash flow was 4.03M and capital expenditures -299,166, giving a free cash flow of 3.73M billion.
- Operating Cash Flow
- 4.03M
- Free Cash Flow
- 3.73M
- Free Cash Flow per Share
- 0.02
Dividends & Yields
Mediwelcome Healthcare Management & Technology Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.81%
- Earnings Yield
- 10.59%
Stock Price Statistics
- Beta
- 0.78
- 52-Week Price Change
- 41.81%
- 50-Day Moving Average
- 1.66
- 200-Day Moving Average
- 1.62
- Relative Strength Index (RSI)
- 49.80
- Average Volume (3m)
- 127.84K
Important Dates
Mediwelcome Healthcare Management & Technology Inc. upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Jul 31, 2026
- Next Earnings Date
- Mar 31, 2027
- Ex-Dividend Date
- ―
Financial Position
Mediwelcome Healthcare Management & Technology Inc. as a current ratio of 1.89, with Debt / Equity ratio of 48.96%
- Current Ratio
- 1.89
- Quick Ratio
- 1.89
- Debt to Market Cap
- 0.22
- Net Debt to EBITDA
- -6.73
- Interest Coverage Ratio
- 1.30
Taxes
In the past 12 months, Mediwelcome Healthcare Management & Technology Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Mediwelcome Healthcare Management & Technology Inc. EV to EBITDA ratio is 12.64, with an EV/FCF ratio of 103.30.
- EV to Sales
- 0.68
- EV to EBITDA
- 12.64
- EV to Free Cash Flow
- 103.30
- EV to Operating Cash Flow
- 95.62
Balance Sheet
Mediwelcome Healthcare Management & Technology Inc. has HKD 138.52M in cash and marketable securities with HKD 65.10M in debt, giving a net cash position of HKD 73.41M billion.
- Cash & Marketable Securities
- HKD 138.52M
- Total Debt
- HKD 65.10M
- Net Cash
- HKD 73.41M
- Net Cash Per Share
- HKD 0.22
- Tangible Book Value Per Share
- -HKD 0.22
Margins
Gross margin is 24.92%, with operating margin of 4.41%, and net profit margin of 5.94%.
- Gross Margin
- 24.92%
- Operating Margin
- 4.41%
- Pretax Margin
- 5.04%
- Net Profit Margin
- 5.94%
- EBITDA Margin
- 5.35%
- EBIT Margin
- 4.41%
Analyst Forecast
The average price target for Mediwelcome Healthcare Management & Technology Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 91.32%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- 5
- AI Score
- 53

